256 related articles for article (PubMed ID: 21369478)
1. Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.
Cho Y; Jung GH; Chung SH; Kim JY; Choi Y; Kim JD
Clin Orthop Surg; 2011 Mar; 3(1):48-54. PubMed ID: 21369478
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Ekert H; Tiedemann K
Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
[No Abstract] [Full Text] [Related]
3. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
[No Abstract] [Full Text] [Related]
4. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Miser JS; Krailo M
Cancer Treat Res; 1993; 62():287-91. PubMed ID: 7682089
[No Abstract] [Full Text] [Related]
6. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Delepine N; Delepine G; Desbois JC
Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
[No Abstract] [Full Text] [Related]
7. The multi-institutional osteosarcoma study: an update.
Link MP
Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
[No Abstract] [Full Text] [Related]
8. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
10. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
Meyers PA; Heller G; Vlamis V
Cancer Treat Res; 1993; 62():309-22. PubMed ID: 7682091
[No Abstract] [Full Text] [Related]
12. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Kalifa C; Razafindrakoto H; Vassal G; Contesso G; Vanel D; Edeline V; Valteau D; Lemerle J
Cancer Treat Res; 1993; 62():347-9. PubMed ID: 7682093
[No Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
[No Abstract] [Full Text] [Related]
15. [Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Kalifa C; Mlika N; Dubousset J; Contesso G; Vanel D; Lumbroso J
Bull Cancer; 1988; 75(2):207-11. PubMed ID: 2451956
[TBL] [Abstract][Full Text] [Related]
16. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
19. Ten years' experience in patients with osteogenic sarcoma in Finland.
Elomaa I; Siimes MA; Blomqvist C; Karaharju E; Ryöppy S; Laasonen E; Holmström T
Eur J Surg Oncol; 1990 Apr; 16(2):147-52. PubMed ID: 1691110
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]